Mar 22, 2018
Symetria Health Has Greater Outcomes In Evidenced Based Addiction Treatment Methods Supported By 2016 Surgeon General's Report
Mar 12, 2018
Orexigen Therapeutics, Inc. Plans For Near-term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code
Feb 20, 2018
Global Addiction Treatment Market: Leading Participants to Focus on Innovation, Says TMR
Feb 06, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
Feb 05, 2018
Global Substance Abuse and Addiction Treatment Market Projected to Grow
Dec 20, 2017
Seven Emmes Employees Recognized in Lancet Study Comparing Two Opioid Treatments
Nov 30, 2017
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
Nov 30, 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA's efforts to promote more widespread innovation and access to opioid addiction treatments
Nov 21, 2017
U.S. FDA Accepts Regulatory Submission and Grants Priority Review for US WorldMeds' Lofexidine
Nov 14, 2017
Although Their Introductions As Treatment Are Different, Two Top Medications For Opioid Addiction Are Equally Effective
Oct 02, 2017
Titan Pharmaceuticals and Opiant Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment
Sep 05, 2017
Salix Announces Four Poster Presentations, Two Product Theatres At PAINWeek 2017